Jefferies Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Jefferies Group’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,275	Closed	-$192K	–	3200
2019 Q2	$183K	Buy	+18,275	New	+$197K	﹤0.01%	2164
2018 Q4	–	Sell	-30,000	Closed	-$600K	–	2764
2018 Q3	$600K	Buy	+30,000	New	+$683K	﹤0.01%	1554
2017 Q1	–	Sell	-50,761	Closed	-$1.77M	–	2770
2016 Q4	$1.77M	Buy	50,761 +35,561	+234%	+$1.06M	0.01%	995
2016 Q3	$373K	Buy	+15,200	New	+$380K	﹤0.01%	1732
2015 Q4	–	Sell	-5,579	Closed	-$222K	–	2669
2015 Q3	$222K	Sell	5,579 -25,762	-82%	-$1.6M	﹤0.01%	1894
2015 Q2	$2.16M	Buy	31,341 +17,681	+129%	+$1.11M	0.01%	875
2015 Q1	$747K	Sell	13,660 -56,694	-81%	-$2.7M	﹤0.01%	1198
2014 Q4	$3M	Buy	70,354 +70,331	+305,787%	+$2.54M	0.02%	573
2014 Q3	$1K	Buy	+23	New	+$490	﹤0.01%	2100

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jefferies Group's AMAG Position: Q3 2019 in Review

Jefferies Group sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 18,275 shares — an estimated $192K sold.

Jefferies Group first reported a position in AMAG in Q3 2014 and held it in 9 quarters. The position peaked at $3M in Q4 2014. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Jefferies Group reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 18,275 AMAG Pharmaceuticals shares in Q3 2019, an estimated $192K.
Jefferies Group first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 9 quarters.
Jefferies Group's AMAG Pharmaceuticals position peaked at $3M in Q4 2014.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.